Towards a Greener Pharmacy by More Eco Design

被引:25
作者
Baron, Michel [1 ]
机构
[1] Univ Toulouse, CNRS, Mines Albi, Ctr Rapsodee,UMR 5302, F-81013 Albi 09, France
关键词
Green pharmacy; Benign by design; Advanced galenics; Green manufacturing; Solvent-free synthesis; Continuous process; ACTIVE PHARMACEUTICAL INGREDIENT; DRUG-DELIVERY; ORAL BIOAVAILABILITY; SURFACE MODIFICATION; WATER; DISSOLUTION; CYCLODEXTRINS; AGGLOMERATION; PARTICLES; CHEMISTRY;
D O I
10.1007/s12649-012-9146-2
中图分类号
X [环境科学、安全科学];
学科分类号
083001 [环境科学];
摘要
This review proposes an overview of the main trends explored by the pharmaceutical industry in order to develop a greener and smarter pharmacy minimizing any negative impact to the environment, and using more sustainable processes and drugs. If many drugs have their origin in nature, many active ingredients are "toxic by design''. Some trials were carried out to design "green pills'', or greener active ingredients "benign by design'', avoiding the environmental pollution risk. More efforts were developed to reduce fine chemicals production footprints, and to decrease their E-factor. Biotechnology, and the use of enzymes for some transformation reactions is another good way of progress. Advanced galenics allows to reduce drug footprints on environment, since it can deliver the right dose of drug at the right time and at the right place, decrease the drug doses, and lower the wastes. Use of continuous processes is a strong trend in the area of primary and secondary pharmaceutical production. It is linked to the quality by design concept and to the in-process control by process analytical technology tools. Added to their diversification strategy, and despite their lower research productivity, and that more and more patented blockbusters become or will become generics soon, it will help the pharmaceutical companies to continue their development. At the same time, these efforts toward a greener pharmacy, and a social education of patients, will contribute to the health organization economies and to preserve the future of our planet.
引用
收藏
页码:395 / 407
页数:13
相关论文
共 99 条
[1]
Preparation of Liposomes Modified with Lipopeptides Using a Supercritical Carbon Dioxide Reverse-phase Evaporation Method [J].
Aburai, Kenichi ;
Yagi, Nobuhiro ;
Yokoyama, Yuusaku ;
Okuno, Hiroaki ;
Sakai, Kenichi ;
Sakai, Hideki ;
Sakamoto, Kazutami ;
Abe, Masahiko .
JOURNAL OF OLEO SCIENCE, 2011, 60 (05) :209-215
[2]
Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles [J].
Agueros, M. ;
Zabaleta, V. ;
Espuelas, S. ;
Campanero, M. A. ;
Irache, J. M. .
JOURNAL OF CONTROLLED RELEASE, 2010, 145 (01) :2-8
[3]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]
[Anonymous], Disposal of unused medicines: what you should know
[5]
[Anonymous], GEMS
[6]
Apoteket AB, 2006, PHARMACEUTICALS
[7]
Avachat AM, 2011, INDIAN J PHARM EDUC, V45, P86
[8]
Backx Ivo, CHANGING CLOCK SPEED
[9]
Controlled Delivery Systems: From Pharmaceuticals to Cells and Genes [J].
Balmayor, Elizabeth Rosado ;
Azevedo, Helena Sepulveda ;
Reis, Rui L. .
PHARMACEUTICAL RESEARCH, 2011, 28 (06) :1241-1258
[10]
Continuous mixing of powder mixtures with pharmaceutical process constraints [J].
Berthiaux, Henri ;
Marikh, Khadija ;
Gatumel, Cendrine .
CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION, 2008, 47 (12) :2315-2322